Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
Relation Therapeutics and GSK enter a $110 million research partnership for AI-driven drug discovery.
Jul 30, 2026•11 days ago
Contract Type
partnership
LondonBiotechnology
Description
Relation Therapeutics has signed a research collaboration agreement with GSK valued at up to $110 million. This partnership aims to create human cellular datasets that will help train AI models for identifying new drug targets.
Company Information
Company
Relation Therapeutics
Location
338 Euston Road
London, England, United Kingdom
About
Relation is pioneering a “Lab-in-the-Loop” that can integrate active learning at every step of drug discovery, from predicting cell states to the validation of new targets. An important challenge for any therapeutics company using machine learning is “ground-truth data,” or information known to be true. Working from real cells provided by proprietary biobanks, Relation’s technology generates genomic data that provide direct insights into critical biological relationships that are fed directly into its ML systems. The platform then requests new experiments to improve its predictive ability, cutting through an otherwise intractable combinatorial space.
LondonBiotechnology